pharma · Neurological Autoimmune Diseases
Juventas Cell Therapy
Juventas Cell Therapy is a pharma organization headquartered in CN. Primary therapeutic focus areas include Neurological Autoimmune Diseases. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent re
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 1
- Patents
- 0
CNCT19 cell injection
Phase 1 · mab · Neurological Autoimmune Diseases
CNCT19 cell injection for Neurological Autoimmune Diseases is a Phase 1 program (mab) at Juventas Cell Therapy with 1 ClinicalTrials.gov record(s).
Internal code HY001021
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Juventas Cell Therapy
- Phase
- Phase 1
- Modality
- mab
- Indication
- Neurological Autoimmune Diseases
- Status
- active
- Trials
- 1